InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Viatris

VTRS Clue Score26
United States Fiscal year ends December CIK 0001792044
$17.64 +1.15% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $17.64 +29.61% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 16 Nov 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue11.27Operating income0.91Net income0.35EPS, diluted0.68Fiscal year 2019Revenue11.37 +0.9%Operating income0.72Net income0.02 −95.2%EPS, diluted0.03Fiscal year 2020Revenue11.82 +4.0%Operating income−0.21Net income−0.67 −4,087.5%EPS, diluted−1.11Fiscal year 2021Revenue17.81 +50.7%Operating income−0.03Net income−1.27EPS, diluted−1.05Fiscal year 2022Revenue16.22 −9.0%Operating income1.61Net income2.08EPS, diluted1.71Fiscal year 2023Revenue15.39 −5.1%Operating income0.77Net income0.05 −97.4%EPS, diluted0.05Fiscal year 2024Revenue14.69 −4.5%Operating income0.01Net income−0.63 −1,259.4%EPS, diluted−0.53Fiscal year 2025Revenue14.25 −3.0%Operating income−2.66Net income−3.51EPS, diluted−3.00
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 11.27 11.37 11.82 17.81 16.22 15.39 14.69 14.25
Growth +0.9% +4.0% +50.7% −9.0% −5.1% −4.5% −3.0%
Operating income 0.91 0.72 −0.21 −0.03 1.61 0.77 0.01 −2.66
Net income 0.35 0.02 −0.67 −1.27 2.08 0.05 −0.63 −3.51
Growth −95.2% −4,087.5% −97.4% −1,259.4%
EPS, diluted 0.68 0.03 −1.11 −1.05 1.71 0.05 −0.53 −3.00

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2018Gross margin35.5%Operating margin8.0%Net margin3.1%Free cash flow margin18.5%Fiscal year 2019Gross margin34.3%Operating margin6.3%Net margin0.1%Free cash flow margin14.0%Fiscal year 2020Gross margin32.1%Operating margin−1.8%Net margin−5.7%Free cash flow margin8.4%Fiscal year 2021Gross margin31.3%Operating margin−0.2%Net margin−7.1%Free cash flow margin14.4%Fiscal year 2022Gross margin40.1%Operating margin10.0%Net margin12.8%Free cash flow margin16.0%Fiscal year 2023Gross margin41.8%Operating margin5.0%Net margin0.4%Free cash flow margin16.4%Fiscal year 2024Gross margin38.3%Operating margin0.1%Net margin−4.3%Free cash flow margin13.5%Fiscal year 2025Gross margin35.2%Operating margin−18.7%Net margin−24.7%Free cash flow margin13.6%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 35.5% 34.3% 32.1% 31.3% 40.1% 41.8% 38.3% 35.2%
Operating margin 8.0% 6.3% −1.8% −0.2% 10.0% 5.0% 0.1% −18.7%
Net margin 3.1% 0.1% −5.7% −7.1% 12.8% 0.4% −4.3% −24.7%
Free cash flow margin 18.5% 14.0% 8.4% 14.4% 16.0% 16.4% 13.5% 13.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow2.34Capital expenditure−0.25Free cash flow2.09Buybacks−0.43Fiscal year 2019Operating cash flow1.80Capital expenditure−0.21Free cash flow1.59 −23.9%Buybacks0.00Fiscal year 2020Operating cash flow1.23Capital expenditure−0.24Free cash flow0.99 −37.8%Buybacks0.00Fiscal year 2021Operating cash flow3.02Capital expenditure−0.46Free cash flow2.56 +158.9%Buybacks0.00Fiscal year 2022Operating cash flow3.00Capital expenditure−0.41Free cash flow2.59 +1.3%Buybacks0.00Fiscal year 2023Operating cash flow2.90Capital expenditure−0.38Free cash flow2.52 −2.7%Buybacks−0.25Fiscal year 2024Operating cash flow2.30Capital expenditure−0.33Free cash flow1.98 −21.6%Buybacks−0.25Fiscal year 2025Operating cash flow2.32Capital expenditure−0.38Free cash flow1.94 −2.0%Buybacks−0.50
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 2.34 1.80 1.23 3.02 3.00 2.90 2.30 2.32
Capital expenditure −0.25 −0.21 −0.24 −0.46 −0.41 −0.38 −0.33 −0.38
Free cash flow 2.09 1.59 0.99 2.56 2.59 2.52 1.98 1.94
Growth −23.9% −37.8% +158.9% +1.3% −2.7% −21.6% −2.0%
Buybacks −0.43 0.00 0.00 0.00 0.00 −0.25 −0.25 −0.50

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash0.39Shareholders’ equity12.17Fiscal year 2019Cash0.48Total debt12.72Net cash (debt)−12.25Shareholders’ equity0.00Fiscal year 2020Cash0.84Total debt24.74Net cash (debt)−23.89Shareholders’ equity22.95Debt to equity1.08Fiscal year 2021Cash0.70Total debt21.59Net cash (debt)−20.89Shareholders’ equity20.49Debt to equity1.05Fiscal year 2022Cash1.26Total debt19.27Net cash (debt)−18.01Shareholders’ equity21.07Debt to equity0.91Fiscal year 2023Cash0.99Total debt18.13Net cash (debt)−17.14Shareholders’ equity20.47Debt to equity0.89Fiscal year 2024Cash0.73Total debt14.05Net cash (debt)−13.31Shareholders’ equity18.64Debt to equity0.75Fiscal year 2025Cash1.32Total debt14.41Net cash (debt)−13.09Shareholders’ equity14.71Debt to equity0.98
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.39 0.48 0.84 0.70 1.26 0.99 0.73 1.32
Total debt n/a 12.72 24.74 21.59 19.27 18.13 14.05 14.41
Net cash (debt) n/a −12.25 −23.89 −20.89 −18.01 −17.14 −13.31 −13.09
Shareholders’ equity 12.17 0.00 22.95 20.49 21.07 20.47 18.64 14.71
Debt to equity n/a n/a 1.08 1.05 0.91 0.89 0.75 0.98

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
11.27 11.37 11.82 17.81 16.22 15.39 14.69 14.25
Growth +0.9% +4.0% +50.7% −9.0% −5.1% −4.5% −3.0%
7.43 7.60 8.15 12.31 9.77 8.99 9.12 9.29
4.00 3.90 3.80 5.58 6.50 6.44 5.62 5.01
Growth −2.6% −2.6% +46.9% +16.5% −0.9% −12.7% −10.8%
0.70 0.64 0.56 0.75 n/a n/a n/a n/a
2.44 2.56 3.34 4.53 4.18 4.07 4.10 3.79
0.91 0.72 −0.21 −0.03 1.61 0.77 0.01 −2.66
Growth −21.0% −129.5% −52.6% −98.7% −26,467.3%
0.30 0.15 −0.72 −0.66 2.81 0.20 −0.62 −3.67
−0.05 0.14 −0.05 0.60 0.73 0.15 0.01 −0.15
0.35 0.02 −0.67 −1.27 2.08 0.05 −0.63 −3.51
Growth −95.2% −4,087.5% −97.4% −1,259.4%
Per share
0.69 0.03 −1.11 −1.05 1.71 0.05 −0.53 −3.00
0.68 0.03 −1.11 −1.05 1.71 0.05 −0.53 −3.00
Growth −95.6% −3,800.0% −97.1% −1,160.0%
514.5 515.7 601.2 1,209 1,212 1,200 n/a n/a
516.5 516.5 601.2 1,209 1,217 1,207 n/a n/a
Growth +0.0% +16.4% +101.1% +0.7% −0.9%

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 3.8% a year over five years.
  • Operating margin is down 16.9 points on five years ago, at -18.7%.
  • A net loss in 4 of 8 years on file.